On air · 1 of 3 networks
Frontier Diagnostics
- frontierdiagnostics.net
- Healthcare & Life Sciences
- 10 employees
Frontier Diagnostics’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 23. Watch Frontier Diagnostics with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 23 | Checked 8 Oct 2026 | See all 23 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 29 Oct 2026 | Collect them with the API → |
Frontier Diagnostics has 23 live LinkedIn ads. We recorded no Google ads on 29 Oct 2026.
Latest ads
- LINKEDIN · IMAGERecorded 20 Sept 2026
Looking for an EIS-qualifying investment opportunity? Frontier Diagnostics is developing Circulating Tumour Cell Technology with the aim of contributing to future advances in oncology, including cancer diagnostics, precision treatment support and recurrence monitoring. Investors may also benefit from Enterprise Investment Scheme, EIS, tax relief, subject to eligibility. Request more information about the company’s technology platform and growth ambitions.
- LINKEDIN · IMAGERecorded 20 Sept 2026
Looking for EIS-qualifying investment opportunity? Frontier Diagnostics is developing Circulating Tumour Cell Technology with the aim of contributing to future advances in oncology, including cancer diagnostics, precision treatment support and recurrence monitoring. Investors may also benefit from Enterprise Investment Scheme, EIS, tax relief, subject to eligibility. Request more information about the company’s technology platform and growth ambitions.
- LINKEDIN · IMAGERecorded 20 Sept 2026
Looking to support early-stage UK biotech innovation? Frontier Diagnostics is developing Circulating Tumour Cell Technology with the aim of contributing to future advances in oncology, including cancer diagnostics, precision treatment support and recurrence monitoring. Investors may also benefit from Enterprise Investment Scheme, EIS, tax relief, subject to eligibility. Request more information about the company’s technology platform and growth ambitions.
- LINKEDIN · IMAGERecorded 20 Sept 2026
Frontier Diagnostics is a UK biotech company developing next-generation Circulating Tumour Cell Technology for oncology. The company is working on technology with potential future applications across cancer diagnostics, precision treatment support and recurrence monitoring. For qualified investors interested in an EIS-eligible UK biotech opportunity. Request more information.
4 of 23 adsSign up to see every Frontier Diagnostics ad, filter by format and date, and get alerts on new ones.
See all 23 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.